# William D. Figg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/william-d-figg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,477 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 102 |
| i10-index | 477 |
| Last Known Institution | Office of the Director |
| OpenAlex ID | https://openalex.org/A5079418869 |
| ORCID iD | https://orcid.org/0000-0003-2428-5613 |
| Works | 1,213 |

## Researcher papers

- [Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group](https://scholariq.org/papers/eligibility-and-response-guidelines-for-phase-ii-clinical-trials-in-androgen/)
- [Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer](https://scholariq.org/papers/redistribution-hyperproliferation-activation-of-natural-killer-cells-and-cd8-t/)
- [Selumetinib in Children with Inoperable Plexiform Neurofibromas](https://scholariq.org/papers/selumetinib-in-children-with-inoperable-plexiform-neurofibromas/)
- [Pharmacogenomics of ABC transporters and its role in cancer chemotherapy](https://scholariq.org/papers/pharmacogenomics-of-abc-transporters-and-its-role-in-cancer-chemotherapy/)
- [Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress](https://scholariq.org/papers/therapeutic-targeting-of-atr-yields-durable-regressions-in-small-cell-lung/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

## Researcher university

- [Office of the Director](https://scholariq.org/institutions/office-of-the-director/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.